F-star Therapeutics, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
7.00
|
|
Average Rating
|
3.00
|
|
# Strong Buys
|
0
|
|
# Buys
|
0
|
|
# Holds
|
5
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.79
|
-0.84
|
-0.05
|
-6.33%
|
|
2022-06-30
|
-0.58
|
-0.88
|
-0.30
|
-51.72%
|
|
2022-03-31
|
-0.67
|
-0.57
|
0.10
|
14.93%
|
|
2021-12-31
|
-0.11
|
0.48
|
0.59
|
536.36%
|
|
2021-09-30
|
-0.58
|
-0.52
|
0.06
|
10.34%
|
|
2021-06-30
|
-0.74
|
-0.92
|
-0.18
|
-24.32%
|
|
2021-03-31
|
-1.16
|
-1.08
|
0.08
|
6.90%
|
|
2020-12-31
|
-0.64
|
-2.10
|
-1.46
|
-228.13%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-2.29
|
|
2021-12-31
|
-2.04
|
|
2020-12-31
|
-6.82
|
|
2019-12-31
|
-5.88
|
|
2018-12-31
|
-2.61
|
|
2017-12-31
|
-2.58
|
|
2016-12-31
|
-7.66
|